GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Synergy Pharmaceuticals Inc (FRA:S90) » Definitions » Short Interest

Synergy Pharmaceuticals (FRA:S90) Short Interest


View and export this data going back to 2012. Start your Free Trial

What is Synergy Pharmaceuticals Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Synergy Pharmaceuticals's Short Interest

For the Drug Manufacturers - Specialty & Generic subindustry, Synergy Pharmaceuticals's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Synergy Pharmaceuticals's Short Interest Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Synergy Pharmaceuticals's Short Interest distribution charts can be found below:

* The bar in red indicates where Synergy Pharmaceuticals's Short Interest falls into.


Synergy Pharmaceuticals (FRA:S90) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Synergy Pharmaceuticals Inc (FRA:S90) » Definitions » Short Interest
Comparable Companies
BOM:523620 OWCP XCNQ:ACG NSE:PARABDRUGS BOM:530317 WAR:SP1 XCNQ:RVV XCNQ:CIG MYHI BOM:524703 BOM:531173 XCNQ:VRT BOM:539938 XPAR:MLGML XCNQ:ASIA PCYN XMAU:GOLI.N0000 XCNQ:OSO BSPK XCNQ:EHC
Traded in Other Exchanges
N/A
Address
420 Lexington Avenue, Suite 2012, New York, NY, USA, 10170
Website
http://www.synergypharma.com
Synergy Pharmaceuticals Inc functions in the healthcare sector based in the United States. It focusses on developing therapies to combat gastrointestinal diseases. The company's basic ingredient is the uroguanylin analog, which it employs in its products candidates such as plecanatide and dolcanatide. Plecanatide is a once-daily tablet, which addresses chronic idiopathic constipation and the irritable bowel syndrome. Dolcanatide is meant to cure inflammatory bowel disease by aiding the process of digestive breakdown.

Synergy Pharmaceuticals (FRA:S90) Headlines

No Headlines